Assignee
MITOBRIDGE INC
US·16 granted patents·8 pending applications·50 citations·filing 2015–2024
Top patents by PatentIndex Score
24 records- 0194US10766888B1HMOX1 inducersMITOBRIDGE INC·Filed 2020·Granted Sep 8, 2020·16 cites·11 claims
- 0294US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 0391US10611790B2Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseasesMITOBRIDGE INC·Filed 2016·Granted Apr 7, 2020·11 cites·17 claims
- 0491US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 0589US10927094B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2017·Granted Feb 23, 2021·3 cites·15 claims
- 0687US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 0787US11530192B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2021·Granted Dec 20, 2022·1 cites·10 claims
- 0884US10906885B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 0984US2024417383A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2024·Application pending·0 cites
- 1083US11034670B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2017·Granted Jun 15, 2021·2 cites·30 claims
- 1182US2023373948A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2023·Application pending·0 cites
- 1280US11912681B2Crystalline and salt forms of PPAR agonist compoundsMITOBRIDGE INC·Filed 2022·Granted Feb 27, 2024·0 cites·9 claims
- 1374US10968172B2USP30 inhibitorsMITOBRIDGE INC·Filed 2018·Granted Apr 6, 2021·1 cites·20 claims
- 1466US11993585B2Poly-ADP ribose polymerase (PARP) inhibitorsMITOBRIDGE INC·Filed 2021·Granted May 28, 2024·0 cites·20 claims
- 1558US2019367457A1Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitorsMITOBRIDGE INC·Filed 2017·Application pending·0 cites
- 1656US2024358681A1Methods of use of ppar agonist compounds and pharmaceutical compositions thereofMITOBRIDGE INC·Filed 2022·Application pending·0 cites
- 1753US2023025807A1Cd38 inhibitorsMITOBRIDGE INC·Filed 2020·Application pending·0 cites
- 1852US2024300933A1Salt and crystal forms of an hmox1 inducerMITOBRIDGE INC·Filed 2022·Application pending·0 cites
- 1951US10874641B2Methods of treating acute kidney injuryMITOBRIDGE INC·Filed 2017·Granted Dec 29, 2020·0 cites·21 claims
- 2046US11358954B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2017·Granted Jun 14, 2022·0 cites·18 claims
- 2143US2021283116A1Methods of treating acute kidney injuryMITOBRIDGE INC·Filed 2017·Application pending·0 cites
- 2240US10188627B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2015·Granted Jan 29, 2019·0 cites·28 claims
- 2335US2017305894A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2015·Application pending·0 cites
- 2433US11168080B2Dynamin-1-like protein inhibitorsMITOBRIDGE INC·Filed 2018·Granted Nov 9, 2021·0 cites·23 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →